1177P Real-world treatment patterns and outcomes in stage III non-small cell lung cancer (NSCLC): Middle East and Africa (MEA)-KINDLE study

A.R Jazieh,E Kaytan Saglam,H.C Önal,Y Abdelkader,R Gaafar,E Dawoud,M Nassar,D Alshorbagy,H El Ashry,M Alsayed

doi:10.1016/j.annonc.2021.08.1781

1177P Real-world treatment patterns and outcomes in stage III non-small cell lung cancer (NSCLC): Middle East and Africa (MEA)-KINDLE study

A.R Jazieh, E Kaytan Saglam + Show 8 more

Open Access

https://doi.org/10.1016/j.annonc.2021.08.1781

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Sep 1, 2021
License type: publisher-specific-oa

Affiliation: Istanbul University, Başkent University, Cairo University, Tawam Hospital, Kuwait Cancer Control Center, Dubai Hospital

#Middle East And Africa #Large Lymph Node Metastases + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Stage III NSCLC comprises a heterogeneous population including large tumours invading surrounding tissues without lymph node metastases to small tumours with large lymph node metastases. Despite therapeutic advances, Stage III NSCLC is associated with a poor prognosis. MEA-KINDLE, as part of a real-world global study, evaluated treatment patterns and survival outcomes in patients with Stage III NSCLC in MEA.

Full Text